Asian lineage of Zika virus

Asian lineage of Zika virus
Name	Asian lineage of Zika virus
Virus group	Flavivirus
Family	Flaviviridae
Genus	Flavivirus
Species	Zika virus
Lineage	Asian lineage
First isolation	1947
Hosts	Aedes aegypti, Aedes albopictus, humans
Transmission	mosquito-borne, vertical, sexual

Contents

Asian lineage of Zika virus is a major phylogenetic clade of Zika virus that has driven 21st-century outbreaks across the Pacific Islands, Americas, and parts of Southeast Asia. It is distinguished by nucleotide substitutions and amino acid changes relative to the African lineage and has been central to research at institutions such as the Centers for Disease Control and Prevention and the World Health Organization during the 2015–2016 epidemic. The lineage's expansion involved collaborations among laboratories at Oswaldo Cruz Foundation, Institut Pasteur, and Walter Reed Army Institute of Research.

Taxonomy and genetic characteristics

The Asian lineage is classified within the family Flaviviridae and genus Flavivirus alongside Dengue virus, Yellow fever virus, and West Nile virus. Comparative genomics published by teams at Harvard University, University of Texas Medical Branch, and Johns Hopkins University identified signature substitutions in the envelope (E) protein and nonstructural proteins NS1, NS3, and NS5 that differentiate the Asian clade from the African clade. Sequence datasets held by GenBank, GISAID, and the European Nucleotide Archive show conserved motifs relevant to viral replication studied by researchers at Cold Spring Harbor Laboratory and Broad Institute. Structural analyses using cryo-EM at Brookhaven National Laboratory and Max Planck Institute revealed changes in virion architecture that may influence tropism, noted by investigators affiliated with Mayo Clinic and Imperial College London.

The Asian lineage first achieved detectable circulation in the Pacific Islands including Yap Island and French Polynesia before arriving in the Americas, with early epidemic sequences linked to travel hubs such as Rio de Janeiro and Miami. Public health responses by Brazilian Ministry of Health, Pan American Health Organization, and European Centre for Disease Prevention and Control mapped rapid spread through Caribbean nations, Colombia, and Mexico. Surveillance studies from Singapore, Thailand, and Vietnam reported endemic transmission, while genetic epidemiology linking cases in Japan, Australia, and New Zealand to the Asian clade was reported by teams at National Institute of Infectious Diseases (Japan) and Australian National University. Modeling work from University of Oxford and Princeton University assessed air travel corridors such as Hartsfield–Jackson Atlanta International Airport and São Paulo–Guarulhos International Airport as conduits for dissemination.

Entomological research by London School of Hygiene and Tropical Medicine and Pasteur Institute New Caledonia established primary vector competence of Aedes aegypti and secondary roles for Aedes albopictus across urban and peri-urban ecologies. Field studies coordinated with Smithsonian Tropical Research Institute and Instituto Evandro Chagas documented seasonal transmission linked to rainfall patterns in regions monitored by National Oceanic and Atmospheric Administration and Meteorological Office (UK). Non-vector transmission modes were characterized in clinical cohorts at Johns Hopkins University School of Medicine and Mount Sinai Hospital, documenting sexual, perinatal, and transfusion-associated cases that informed guidance from Food and Drug Administration and European Medicines Agency.

Clinical cohorts at Universidade Federal do Rio de Janeiro, Hospital das Clínicas, and University of California, San Francisco linked Asian-lineage infections to increases in microcephaly and congenital Zika syndrome observed during the 2015–2016 epidemic, prompting emergency declarations by the World Health Organization and policy actions by the United States Centers for Disease Control and Prevention. Case series at University of Miami Miller School of Medicine and University of Toronto described neurological complications including Guillain–Barré syndrome and ocular anomalies, which influenced guidance from American Academy of Pediatrics and Royal College of Obstetricians and Gynaecologists. Health economics analyses by World Bank and Bill & Melinda Gates Foundation partners estimated substantial socioeconomic burdens in affected regions, informing aid programs administered by United Nations Children's Fund and Médecins Sans Frontières.

Phylogenetic reconstructions using sequences from GenBank and analysis pipelines developed at University of Cambridge and Swiss Institute of Bioinformatics place the Asian lineage in a monophyletic clade that diverged from the African lineage early in the 20th century. Studies led by researchers at Scripps Research, University of Oxford, and Columbia University used Bayesian dating methods implemented in software from University of Auckland and Max Planck Institute for Evolutionary Anthropology to estimate timing of diversification preceding Pacific outbreaks. Viral migration analyses integrating travel data from International Air Transport Association and population genetics from Wellcome Sanger Institute have traced multiple introductions into the Americas, corroborated by case investigations by Pan American Health Organization and national public health laboratories.

Diagnostic capacity expanded through real-time RT-PCR assays developed at Centers for Disease Control and Prevention, serological platforms refined by Institut Pasteur and neutralization tests validated by World Health Organization reference laboratories. Surveillance networks coordinated by Pan American Health Organization, European Centre for Disease Prevention and Control, and national agencies like Ministry of Health (Brazil) integrated sentinel reporting, vector surveillance by entomological institutes, and genomic sequencing in consortia with Chan Zuckerberg Initiative and Wellcome Trust. Control measures emphasized vector control programs executed by municipal authorities in Fortaleza, San Juan, and Bangkok; vaccine development by partnerships including National Institutes of Health and pharmaceutical firms such as GlaxoSmithKline and Sanofi progressed through preclinical and clinical trials influenced by regulatory frameworks from Food and Drug Administration and European Medicines Agency.

Category:Zika virus Category:Flaviviruses